Immediate Impact
47 standout
Citing Papers
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
Works of Narayanan Srihari being referenced
Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Narayanan Srihari | 67 | 47 | 35 | 46 | 8 | 126 | |
| Kristina Williams | 52 | 28 | 50 | 38 | 8 | 144 | |
| Amy Sion | 91 | 37 | 31 | 111 | 8 | 224 | |
| Fabien Calvo | 64 | 90 | 72 | 70 | 7 | 210 | |
| Paul Westwood | 48 | 27 | 96 | 69 | 9 | 183 | |
| Mirjam de With | 27 | 18 | 64 | 78 | 13 | 169 | |
| Thomas H. Openshaw | 37 | 104 | 18 | 97 | 12 | 183 | |
| Jan B. Ruit | 38 | 38 | 64 | 142 | 6 | 198 | |
| Benjamin T. Marchello | 51 | 10 | 39 | 140 | 10 | 206 | |
| Krystyna Reczko | 39 | 55 | 19 | 75 | 10 | 187 | |
| Cheryl J. Smith | 33 | 38 | 44 | 70 | 10 | 161 |
All Works
Login with ORCID to disown or claim papers
Loading papers...